Patients Products Career About company Contacts ? Important safety information for NovoPen Echo ® injectors More information in the press release Press release Areas of activity Diabetes Hemophilia Growth hormone therapy Obesity New! NovoPen Echo ® red is available in Russia! Russian production A high-tech plant for the production of modern insulin is located in the Kaluga Region on the territory of the Grabtsevo Technopark. More .. Contacts LLC "Novo Nordisk" Russia, Moscow 121 614 Krylatskaya st., 15 office 41 Krylatskie Hills Business Park Tel .: +7 495 956-11-32 Fax: +7 495 956-50-13 Email: russia_info@novonordisk.com Report an adverse event About us Novo Nordisk is a global pharmaceutical company with over 90 years of history of innovation and a world leader in the development and manufacture of drugs for the treatment of diabetes and obesity. The company also holds leading positions in areas such as hemostasis management and growth hormone therapy. The headquarters of Novo Nordisk is located in Denmark. More than 42,300 employees work in 77 branches of the company around the world. Novo Nordisk Sites NovoNordisk.com Or choose: Websites of other countries Other sites Novo Nordisk worldwide Map, addresses, and route planning © 2015 Novo Nordisk A / S Information and confidentiality